Prediction: Lilly Will Trade at $1,200 by Year-End
Investors weigh a bold forecast that Eli Lilly could hit $1,200 by year-end 2026, betting on GLP-1 drugs and a robust...
Utilize your home equity as a powerful tool to eliminate debt. Explore options that can help you regain financial stability.
23,247 articlesInvestors weigh a bold forecast that Eli Lilly could hit $1,200 by year-end 2026, betting on GLP-1 drugs and a robust...
A new five-pillar framework unveiled by a top U.S. official signals a hard turn toward reshoring, tougher trade terms...
AI is reshaping business, and a few durable names stand to benefit for years. Here are three artificial intelligence ...
Analysts see a constructive Alphabet stock price prediction as cloud momentum and AI investments gain traction. The f...
Famed investor Michael Burry reportedly tacks a bearish stance onto Micron Technology, signaling renewed caution for ...
As SpaceX gears up for a potential IPO, spacex’s lead underwriters have produced a dramatic split in value views, cre...
Investors weigh COPX, the copper miners ETF, against CPER, a copper futures fund, as EV and grid investments push cop...
The YieldMax COIN Option Income Strategy ETF, ticker CONY, endured a steep 56.25% decline in the latest year, with di...
Vanguard's Dividend Appreciation ETF (VIG) yields about 1.5% today, but behind that modest payout lies a 20-year stre...
After a long hiatus from the tech scene, Peter Steinberger—a millennial coder turned OpenClaw founder—re-emerged to w...
Fresh analyst calls on Tuesday cover a diverse set of names from Blackstone to Qualcomm, signaling continued caution ...
Lawmakers push for AI safety, privacy, and energy rules. Investors weigh how regulation could affect big AI players a...